Education
About Us
Working with TipRanks
Follow Us
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 23.95M | $ 0.00 | $ 0.00 | - | $ 0.00 |
| Gross Profit | $ 22.94M | $ -992.56K | $ -671.42K | $ 0.00 | $ -1.69M |
| Operating Income | $ -1.73M | $ -26.79M | $ -22.26M | $ -28.60M | $ -12.95M |
| EBITDA | $ -268.02K | $ -22.33M | $ -21.54M | $ -28.03M | $ -6.63M |
| Net Income | $ -565.77K | $ -23.19M | $ -21.65M | $ -22.94M | $ -8.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 14.21B | $ 12.61M | $ 8.06M | $ 23.09M | $ 21.41M |
| Total Assets | $ 28.59B | $ 27.65M | $ 19.39M | $ 44.93M | $ 40.77M |
| Total Debt | $ 116.31M | $ 272.74K | $ 257.55K | $ 477.15K | $ 652.04K |
| Net Debt | $ -14.09B | $ -12.34M | $ -7.80M | $ -22.61M | $ -20.76M |
| Total Liabilities | $ 9.59B | $ 10.16M | $ 4.74M | $ 5.78M | $ 5.01M |
| Stockholders' Equity | $ 19.00B | $ 17.49M | $ 14.65M | $ 39.15M | $ 35.76M |
| Cash Flow | |||||
| Free Cash Flow | $ 77.23M | $ -14.68M | $ -9.85M | $ -14.97M | $ -5.67M |
| Operating Cash Flow | $ 77.23M | $ -14.68M | $ -9.85M | $ -14.97M | $ -5.66M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 427.68K | $ -60.26K |
| Financing Cash Flow | $ 1.53B | $ 15.11M | $ 2.60M | $ 18.57M | $ 23.71M |
Neuphoria Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.